Targeted Therapy in CD38+Acute Myeloid Leukemia

被引：2
|
作者：
Hu, Naibo [1 ]
Gao, Chao [1 ]
Zhang, Yuhui [1 ]
Teng, Guangshuai [1 ]
Wang, Yan [1 ]
Du, Chenxiao [1 ]
Bai, Jie [1 ]
机构：
[1] Tianjin Med Univ, Hosp 2, Dept Hematol, Tianjin, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4425
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia
    Naik, Jyoti
    Themeli, Maria
    de Jong-Korlaar, Regina
    Ruiter, Ruud W. J.
    Poddighe, Pino J.
    Yuan, Huipin
    Bruijn, Joost D. d.
    Ossenkoppele, Gert J.
    Zweegman, Sonja
    Smit, Linda
    Mutis, Tuna
    Martens, Anton C. M.
    de Donk, Niels W. C. J. van
    Groen, Richard W. J.
    HAEMATOLOGICA, 2019, 104 (03) : E100 - E103
  • [42] Aclinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
    Gerber, Jonathan M.
    Smith, B. Douglas
    Ngwang, Brownhilda
    Zhang, Hao
    Vala, Milada S.
    Morsberger, Laura
    Galkin, Steven
    Collector, Michael I.
    Perkins, Brandy
    Levis, Mark J.
    Griffin, Constance A.
    Sharkis, Saul J.
    Borowitz, Michael J.
    Karp, Judith E.
    Jones, Richard J.
    BLOOD, 2012, 119 (15) : 3571 - 3577
  • [43] Evolution of natural killer cell-targeted therapy for acute myeloid leukemia
    Kaito, Yuta
    Imai, Yoichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 34 - 43
  • [44] Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches
    Winer, Eric S.
    Stone, Richard M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [45] Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia
    Huang, Jingcao
    Lyu, Hui
    Wu, Ying
    Liu, Bolin
    CANCER RESEARCH, 2015, 75
  • [46] Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia
    Zhao, Nianxi
    Pei, Sung-Nan
    Qi, Jianjun
    Zeng, Zihua
    Iyer, Swaminathan P.
    Lin, Pei
    Tung, Ching-Hsuan
    Zu, Youli
    BIOMATERIALS, 2015, 67 : 42 - 51
  • [47] Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia
    Huang, Jingcao
    Lyu, Hui
    Wang, Jianxiang
    Liu, Bolin
    CANCER LETTERS, 2015, 366 (02) : 160 - 172
  • [48] Cell surface receptor-targeted therapy of acute myeloid leukemia: A review
    Frankel, AE
    Sievers, EL
    Scheinberg, DA
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2000, 15 (05) : 459 - 476
  • [49] The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
    Huang, Wanxue
    Sun, Gongrui
    Wang, Qi
    Long, Zhiguo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
    Elgamal, Ola A.
    Fobare, Sydney
    Vibhute, Sandip
    Mehmood, Abeera
    Vroom, Dennis C.
    Johnson, Mariah L.
    Stearns, Blaise
    Lerma, James R.
    Truxall, Jean
    Stahl, Emily
    Carmichael, Bridget
    Orwick, Shelley J.
    Mims, Alice S.
    Curran, Emily
    Santhanam, Ramasamy
    Tridandapani, Susheela
    Phelps, Mitch A.
    Xie, Zhiliang
    Coss, Christopher C.
    Baker, Sharyn D.
    Patrick, Jeffrey
    Ezzell, Janel K.
    Rai, Jayesh
    Pan, Jianmin
    Rai, Shesh N.
    Stillwell, Cody
    Wunderlich, Mark
    Abdulrahim, Mouad
    Goodwin, Thomas E.
    Hilinski, Gerard
    Bennett, Chad E.
    Hertlein, Erin
    Byrd, John C.
    JCI INSIGHT, 2024, 9 (08)
12345